Management of Diastolic Hypotension with Systolic Hypertension

Target Blood Pressure Goals

The primary target is systolic BP <140 mmHg while maintaining diastolic BP ≥70 mmHg to balance cardiovascular risk reduction against the risk of tissue hypoperfusion 1, 2
The 70 mmHg diastolic threshold is critical because coronary perfusion occurs primarily during diastole, and renal perfusion pressure depends on adequate diastolic pressure 2
In high-risk patients with established coronary artery disease, the diastolic BP ≥70 mmHg threshold becomes even more important to prevent myocardial ischemia 2

Verify hypertension diagnosis with out-of-office measurements (home BP monitoring or ambulatory BP monitoring) to exclude white-coat hypertension 1
Measure BP in both sitting and standing positions, as elderly patients with this pattern are at increased risk for orthostatic hypotension 3, 4
Assess for symptoms of hypoperfusion including dizziness, fatigue, syncope, worsening renal function, or cardiac ischemia 2
Identify high-risk features: established coronary artery disease, diabetes, older age, or elevated cardiac biomarkers suggesting myocardial injury 2

Start with monotherapy at the lowest recommended dose, as this pattern is common in elderly patients who are more susceptible to adverse effects 4, 1
ACE inhibitors or ARBs are recommended as first-line agents for isolated systolic hypertension, as they improve aortic distensibility and preferentially lower systolic more than diastolic pressure 1
Thiazide diuretics or calcium channel blockers (particularly dihydropyridines) are alternative first-line options supported by randomized trials in isolated systolic hypertension 3, 4
Avoid or use beta-blockers cautiously, as they may have less pronounced cardiovascular benefit in elderly patients and can exacerbate diastolic hypotension 3

If monotherapy is partially effective, add a small dose of a second drug from a different class rather than increasing the first drug's dose 1
Initial doses and subsequent titration should be more gradual in elderly and frail patients due to greater risk of adverse effects 4
Monitor BP every 2-4 weeks during titration and every 3-6 months once controlled 1

Review and modify the current antihypertensive regimen if therapy is causing excessive diastolic BP reduction 2
Consider reducing or discontinuing medications that preferentially lower diastolic pressure (such as diuretics or vasodilators) 2
Accept higher systolic BP targets (e.g., 140-160 mmHg) to maintain adequate diastolic pressure in patients with coronary artery disease or symptomatic hypoperfusion 2
Avoid increasing antihypertensive medication when diastolic BP is already in the 50s-60s to prevent compromised coronary perfusion 2

Patients with pre-existing coronary heart disease should not have diastolic BP reduced below 70 mmHg, as post-hoc analyses from SHEP identified diastolic BP <70 mmHg as associated with poorer outcomes 2
The Syst-Eur trial suggested diastolic BP down to 55 mmHg may not be harmful except in patients with coronary heart disease, but this should not guide treatment targets 2

Prioritize preventing symptomatic hypoperfusion and myocardial ischemia over achieving systolic targets in difficult cases 2
Consider optimizing cardiac output through heart failure management if present, rather than manipulating blood pressure directly 2

Ensure adequate hydration and optimize fluid management, particularly in patients with low cardiac output states 2